The mean age of these patients was 60.5 years and all of them suffered from high-grade serous ovarian cancer with different variants of BRCA1 and BRCA2. The characteristics of their tumors are summarized in Table 2. This evidence concerns the gene BRCA2 and ovarian serous adenocarcinoma.